series-c-plus
Stage
1
Investors
About
MuReva Phototherapy develops a medical device that uses photobiomodulation therapy to reduce the severity of oral mucositis in cancer patients undergoing radiation and chemotherapy.
Explore MuReva Phototherapy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.